about
What We Can Learn from "Super-responders".Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study.Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.Primary prevention of sudden cardiac death: can we afford the cost of cardioverter-defibrillators? Data from the Search-MI Registry-Italian sub-study.Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial[How is syncope studied in the Italian hospitals?].The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004.Monomorphic ventricular tachycardia in 'Brugada syndrome': clinical case and literature review.A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prTrend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the quinquennium 2003-07.Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCERisk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
P50
Q30240633-3AB765AF-FCD2-4204-AB9B-AEF5A3CA4770Q30564158-89F3D35A-2430-4913-866E-697603C94846Q30584441-500DDFB5-A8F0-4845-ABD5-433C548AA082Q30823317-6417BBAB-A16B-4B17-8C33-9F2AE35234F7Q31085557-27935358-A2F2-4BA4-A3B8-661704AB3133Q31119225-E34A274E-72EA-4FFC-BCC4-257EE8AADE9BQ33151893-CCDDD6EA-50CF-4383-A306-04AA025FD6DFQ33152652-FD569CA9-8660-433B-B7CF-1971FFD0AE9AQ33154567-89D9E619-F42E-439E-AF80-9B56A1560E63Q33156432-EBA9340C-66C3-4EB2-B17C-6DC63E02FA15Q33157547-2544883F-2921-4BEB-A8C1-C856D9BDC248Q33158042-117B7E19-2DFB-46C7-B029-A3D8E9965280Q33158266-03FF79D5-368B-4E55-BAF8-58843ABFDA78Q33159349-19BB6E1D-91D3-48B2-BAAC-C9E910CAB757Q33162745-ED799023-C451-41AB-988E-819089D0175CQ33166757-5F4F4887-F677-4C2C-8980-7DEB9FE3BB01
P50
description
onderzoeker
@nl
name
Alessandro Proclemer
@ast
Alessandro Proclemer
@en
Alessandro Proclemer
@es
Alessandro Proclemer
@nl
Alessandro Proclemer
@sl
type
label
Alessandro Proclemer
@ast
Alessandro Proclemer
@en
Alessandro Proclemer
@es
Alessandro Proclemer
@nl
Alessandro Proclemer
@sl
prefLabel
Alessandro Proclemer
@ast
Alessandro Proclemer
@en
Alessandro Proclemer
@es
Alessandro Proclemer
@nl
Alessandro Proclemer
@sl